Core Insights - The company reported a revenue of 2.75 billion yuan for the first half of 2025, representing a year-on-year growth of 15.9% [1] - The net profit attributable to shareholders for the same period was 340 million yuan, an increase of 15.2% year-on-year [1] - In Q2 2025, the company achieved a revenue of 1.56 billion yuan, showing a year-on-year growth of 10.2% and a quarter-on-quarter increase of 31.4% [1] Financial Performance - The injection molding machine segment generated a revenue of 1.93 billion yuan in H1 2025, with a year-on-year growth of 13.1% and a gross margin of 30.5%, slightly down by 0.4 percentage points [1] - The die-casting machine segment achieved a revenue of 560 million yuan in H1 2025, reflecting a significant year-on-year growth of 33.3%, although the gross margin decreased by 2.12 percentage points to 31.5% [1] - The overall gross margin for H1 2025 was 31.1%, down by 2.5 percentage points year-on-year, while the net profit margin remained stable at 12.9% [2] Cost Management - In H1 2025, the company maintained effective cost control, with a total expense ratio of 17.2%, down by 2.7 percentage points year-on-year [2] - The selling expense ratio was 7.5%, a decrease of 2.0 percentage points year-on-year, while the management expense ratio slightly increased to 5.0% [2] - R&D expenses accounted for 4.9% of revenue, down by 0.4 percentage points year-on-year, indicating a focus on maintaining profitability [2] Future Outlook - The company forecasts net profits of 720 million yuan, 850 million yuan, and 1 billion yuan for 2025, 2026, and 2027 respectively, with an expected compound annual growth rate of 18% [2] - The projected earnings per share (EPS) for the next three years are 1.53 yuan, 1.81 yuan, and 2.14 yuan [2]

Investment Rating - The report maintains a "Strong Buy" rating for the company [1][2]. Core Insights - The company is expected to achieve steady growth in 2024, with a year-on-year revenue increase of 23.61% to reach 5.063 billion yuan and a net profit growth of 27.42% to 608 million yuan [6]. - The injection molding machine business continues to lead the industry, with revenue growth of 28.80% year-on-year, outperforming the overall market [6]. - The automotive and 3C sectors remain the largest demand sources, with significant year-on-year growth rates of 16.7% and 63.6%, respectively [6]. - New products are being launched, including the A6 series high-end intelligent injection molding machines and NEXT² series die-casting machines, which support capacity expansion and performance growth [6]. Financial Performance - In Q1 2025, the company reported a revenue of 1.187 billion yuan, a year-on-year increase of 24.32%, and a net profit of 132 million yuan, up 14.29% [6]. - The company’s total revenue for 2024 is projected to be 5.699 billion yuan, with a year-on-year growth of 13% in 2025 [8]. - The gross profit margin for injection molding machines was 31.78% in 2024, slightly down by 1.52 percentage points year-on-year [6]. Market Position - The company is recognized as a leader in the injection molding machine sector, with its revenue performance consistently exceeding industry averages [6]. - The overall market for plastic processing equipment in China is expected to grow by 5.3% in 2024, indicating a favorable environment for the company’s growth [6]. Shareholder Information - The major shareholder, Jiazhuo Holdings Limited, holds a 29.32% stake in the company [2].